Viiv Health Care Apretude

Listing Websites about Viiv Health Care Apretude

Filter Type:

ViiV Healthcare announces FDA approval of Apretude …

(1 days ago) WebLondon, 21 December 2021 – ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (GSK), with Pfizer Inc. and Shionogi Limited as …

https://viivhealthcare.com/hiv-news-and-media/news/press-releases/2021/december/viiv-healthcare-announces-fda-approval-of-apretude/

Category:  Health Show Health

CENTER FOR DRUG EVALUATION AND RESEARCH - Food and …

(1 days ago) WebViiV Healthcare Company Approval Date: December 20, 2021 Indication: APRETUDE is an HIV-1 integrase strand transfer the risk of sexually acquired HIV-1 infection. …

https://www.accessdata.fda.gov/drugsatfda_docs/nda/2022/215499Orig1s000Approv.pdf

Category:  Health Show Health

ViiV Healthcare : FDA Approves Apretude, Long-acting - Nasdaq

(2 days ago) WebViiV Healthcare noted that it will begin shipping Apretude to wholesalers and specialty distributors in the US in early 2022. ViiV Healthcare has initiated …

https://www.nasdaq.com/articles/viiv-healthcare-%3A-fda-approves-apretude-long-acting-injectable-option-for-hiv-prevention

Category:  Health Show Health

GlaxoSmithKline’s HIV prevention injectable Apretude threatens …

(7 days ago) WebViiV is offering Apretude at the wholesale acquisition cost of $3,700 per vial, a company spokesperson told Fierce Pharma. Given its bimonthly dosing, Apretude …

https://www.fiercepharma.com/pharma/glaxosmithkline-first-long-acting-hiv-prep-injectable-apretude-fda-approval-threaten-gilead

Category:  Health Show Health

ViiV Healthcare : FDA Approves Apretude, Long-acting Injectable …

(5 days ago) WebViiV Healthcare noted that it will begin shipping Apretude to wholesalers and specialty distributors in the US in early 2022. ViiV Healthcare has initiated …

https://markets.businessinsider.com/news/stocks/viiv-healthcare-fda-approves-apretude-long-acting-injectable-option-for-hiv-prevention-1031058136

Category:  Health Show Health

Home APRETUDE (cabotegravir 200 mg/mL) HCP Website

(4 days ago) WebDESCOVY and TRUVADA are owned by Gilead Sciences, Inc. All other trademarks are owned by or licensed to the ViiV Healthcare group of companies. This site is funded and …

https://apretudehcp.com/

Category:  Health Show Health

ViiV Healthcare announces US FDA approval of Apretude - GSK

(Just Now) WebViiV Healthcare will begin shipping Apretude to wholesalers and specialty distributors in the US in early 2022. ViiV Healthcare has initiated submissions to other …

https://us.gsk.com/en-us/media/press-releases/viiv-healthcare-announces-us-fda-approval-of-apretude-cabotegravir-extended-release-injectable-suspension-the-first-and-only-long-acting-injectable-option-for-hiv-prevention/

Category:  Health Show Health

ViiV Healthcare receives EC approval for Apretude to prevent HIV

(Just Now) WebThe European Commission has approved ViiV Healthcare’s Apretude (cabotegravir long-acting (LA) injectable and tablets) to prevent HIV (human …

https://www.ns-healthcare.com/news/viiv-healthcare-receives-ec-approval-for-apretude-to-prevent-hiv/

Category:  Health Show Health

FDA Approves Apretude, the First, Only Long-acting Injectable …

(Just Now) WebThe FDA has approved the first and only long-acting injectable pre-exposure prophylaxis (PrEP) option (Apretude, ViiV Healthcare) to reduce the risk of acquiring HIV-1 in …

https://www.pharmacytimes.com/view/fda-approves-apretude-the-first-only-long-acting-injectable-option-for-hiv-prevention

Category:  Health Show Health

Apretude (ViiV Healthcare Company): FDA Package Insert

(4 days ago) WebAPRETUDE b. 600 mg (3 mL) Table 2. Recommended Dosing Schedule (Direct to Injection) for Pre‑Exposure Prophylaxis in Adults and Adolescents Weighing at …

https://medlibrary.org/lib/rx/meds/apretude/

Category:  Health Show Health

UK MHRA approves ViiV Healthcare’s cabotegravir formulations …

(8 days ago) WebThe UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted approval for two new formulations of ViiV Healthcare’s cabotegravir, offering a …

https://finance.yahoo.com/news/uk-mhra-approves-viiv-healthcare-082214173.html

Category:  Medicine Show Health

New cabotegravir formulations approved to help prevent HIV-1 …

(1 days ago) WebThe Medicines and Healthcare products Regulatory Agency (MHRA) has today (3 May 2024) approved two new formulations of the medicine cabotegravir (Apretude 30 …

https://www.gov.uk/government/news/new-cabotegravir-formulations-approved-to-help-prevent-hiv-1-infection-in-adults-and-adolescents

Category:  Medicine Show Health

Donald O'Boyle 2nd - Scientific Leader - ViiV Healthcare - LinkedIn

(5 days ago) WebLiked by Donald O'Boyle 2nd. Experienced "Hands-on" bench scientist with current emphasis on HIV infection and methods to interfere with replication/latency …

https://www.linkedin.com/in/donald-o-boyle-2nd-1aba2536

Category:  Health Show Health

AliveDrip IV Therapy IV Vitamins Infusions IV Drips Longevity

(2 days ago) WebENHANCE YOUR QUALITY OF LIFE. Alivedrip is an IV vitamin infusion center with a health and wellness approach developed by physicians and affiliates. Our tailored IV …

https://alivedrip.com/

Category:  Vitamin Show Health

ViiV Healthcare announces US FDA approval of Apretude …

(4 days ago) WebViiV Healthcare will begin shipping Apretude to wholesalers and specialty distributors in the US in early 2022. ViiV Healthcare has initiated submissions to other …

https://financialpost.com/pmn/press-releases-pmn/business-wire-news-releases-pmn/viiv-healthcare-announces-us-fda-approval-of-apretude-cabotegravir-extended-release-injectable-suspension-the-first-and-only-long-acting-injectable-option-for-hiv-prevention

Category:  Health Show Health

GSK’s ViiV Sues Hetero to Block Copies of Tivicay HIV Drug

(4 days ago) WebGlaxoSmithKline Plc’s ViiV Healthcare Co. alleges in a federal lawsuit that Hetero Labs Ltd.’s proposed copy of the blockbuster Tivicay infringes a patent for the …

https://news.bloomberglaw.com/ip-law/gsks-viiv-sues-hetero-to-block-copies-of-tivicay-hiv-drug

Category:  Health Show Health

Apretude approved by Medicines and Healthcare products …

(5 days ago) WebWe are pleased to share the news that ViiV Healthcare has received marketing authorisation from the Medicines and Healthcare products Regulatory Agency (MHRA) …

https://viivhealthcare.com/hiv-news-and-media/news/company-statements/apretude-approved-by-medicines-and-healthcare-products/

Category:  Medicine Show Health

ViiV Healthcare announces US FDA approval of Apretude - GSK

(1 days ago) WebViiV Healthcare will begin shipping Apretude to wholesalers and specialty distributors in the US in early 2022. ViiV Healthcare has initiated submissions to other …

https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-announces-us-fda-approval-of-apretude-cabotegravir-extended-release-injectable-suspension-the-first-and-only-long-acting-injectable-option-for-hiv-prevention/

Category:  Health Show Health

TOP 10 Private Caregivers in North Bergen, NJ - Affordable Rates

(7 days ago) WebAverage Rating 5.0 / 5. Caregivers in North Bergen, NJ are rated 5.0 out of 5 stars based on 6 reviews of the 60 listed caregivers. Find 60 affordable caregivers in North Bergen, NJ, …

https://www.care.com/caregivers/north-bergen-nj

Category:  Health Show Health

ViiV Healthcare announces US FDA approval of Apretude …

(Just Now) WebViiV Healthcare will begin shipping Apretude to wholesalers and specialty distributors in the US in early 2022. ViiV Healthcare has initiated submissions to other …

https://www.businesswire.com/news/home/20211220005863/en/ViiV-Healthcare-announces-US-FDA-approval-of-Apretude-cabotegravir-extended-release-injectable-suspension-the-first-and-only-long-acting-injectable-option-for-HIV-prevention

Category:  Health Show Health

WORLDWIDE REGISTRATION

(1 days ago) WebThis document was prepared on 03 May 2024 and will be updated on a quarterly basis by ViiV Healthcare. It is made available for information purposes only …

https://viivhealthcare.com/content/dam/cf-viiv/viivhealthcare/en_GB/pdf/cab-prep-wwrs-03-may-2024.pdf

Category:  Health Show Health

ViiV Healthcare announces FDA approval of Apretude

(9 days ago) WebViiV Healthcare will begin shipping Apretude to wholesalers and specialty distributors in the US in early 2022. ViiV Healthcare has initiated submissions to other …

https://markets.ft.com/data/announce/full?dockey=1323-15258796-0jrd2u107g6p28ma08uq6ssomt

Category:  Health Show Health

Filter Type: